These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28817982)

  • 1. Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
    Segelov E; Lordick F; Goldstein D; Chantrill LA; Croagh D; Lawrence B; Arnold D; Chau I; Obermannova R; Price TJ
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):951-964. PubMed ID: 28817982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
    Nguyen M; Segelov E; Goldstein D; Pavlakis N; Shapiro J; Price TJ; Nagrial A; Chantrill L; Leong T; Chen J; Burge M; Karapetis CS; Chau I; Lordick F; Renouf D; Tebbutt N; Roy AC
    Expert Rev Anticancer Ther; 2022 Jan; 22(1):39-51. PubMed ID: 34739362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?
    Brunner TB
    Curr Oncol Rep; 2013 Apr; 15(2):162-9. PubMed ID: 23325567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidences and opinions for adjuvant therapy in pancreatic cancer.
    Reni M
    Curr Drug Targets; 2012 Jun; 13(6):789-94. PubMed ID: 22458525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Clinical Trials in Pancreatic Cancer.
    Goel N; Reddy SS
    Surg Oncol Clin N Am; 2017 Oct; 26(4):767-790. PubMed ID: 28923230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
    Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatments for resectable pancreatic cancer.
    Ueno H; Kosuge T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern diagnosis and treatment of pancreatic cancer--from the viewpoint of the internist].
    Horvát-Karajz K
    Orv Hetil; 2005 Feb; 146(7):305-8. PubMed ID: 15782793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current standards and new innovative approaches for treatment of pancreatic cancer.
    Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
    Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the management of pancreatic adenocarcinoma.
    Karakas Y; Lacin S; Yalcin S
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):51-62. PubMed ID: 29125367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer: current and future treatment strategies.
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy of pancreatic cancer.
    Willett CG; Czito BG; Bendell JC
    Cancer J; 2007; 13(3):185-91. PubMed ID: 17620768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions.
    Brunner M; Wu Z; Krautz C; Pilarsky C; Grützmann R; Weber GF
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant therapy in pancreatic cancer].
    Ji JF; Li ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):644-7. PubMed ID: 16274051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to define and manage borderline resectable pancreatic cancer.
    Papavasiliou P; Chun YS; Hoffman JP
    Surg Clin North Am; 2013 Jun; 93(3):663-74. PubMed ID: 23632151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New techniques and agents in the adjuvant therapy of pancreatic cancer.
    Raraty MG; Magee CJ; Ghaneh P; Neoptolemos JP
    Acta Oncol; 2002; 41(7-8):582-95. PubMed ID: 14651201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
    Roy AC; Shapiro J; Burge M; Karapetis CS; Pavlakis N; Segelov E; Chau I; Lordick F; Chen LT; Barbour A; Tebbutt N; Price T
    Expert Rev Anticancer Ther; 2020 Apr; 20(4):305-324. PubMed ID: 32202178
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy.
    Evans DB; George B; Tsai S
    Ann Surg Oncol; 2015 Oct; 22(11):3409-13. PubMed ID: 26122369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.